Direkt zum Inhalt
Merck
  • Translocation of the papillomavirus L2/vDNA complex across the limiting membrane requires the onset of mitosis.

Translocation of the papillomavirus L2/vDNA complex across the limiting membrane requires the onset of mitosis.

PLoS pathogens (2017-05-04)
Christine M Calton, Matthew P Bronnimann, Ariana R Manson, Shuaizhi Li, Janice A Chapman, Marcela Suarez-Berumen, Tatum R Williamson, Sudheer K Molugu, Ricardo A Bernal, Samuel K Campos
ZUSAMMENFASSUNG

The human papillomavirus type 16 (HPV16) L2 protein acts as a chaperone to ensure that the viral genome (vDNA) traffics from endosomes to the trans-Golgi network (TGN) and eventually the nucleus, where HPV replication occurs. En route to the nucleus, the L2/vDNA complex must translocate across limiting intracellular membranes. The details of this critical process remain poorly characterized. We have developed a system based on subcellular compartmentalization of the enzyme BirA and its cognate substrate to detect membrane translocation of L2-BirA from incoming virions. We find that L2 translocation requires transport to the TGN and is strictly dependent on entry into mitosis, coinciding with mitotic entry in synchronized cells. Cell cycle arrest causes retention of L2/vDNA at the TGN; only release and progression past G2/M enables translocation across the limiting membrane and subsequent infection. Microscopy of EdU-labeled vDNA reveals a rapid and dramatic shift in vDNA localization during early mitosis. At late G2/early prophase vDNA egresses from the TGN to a pericentriolar location, accumulating there through prometaphase where it begins to associate with condensed chromosomes. By metaphase and throughout anaphase the vDNA is seen bound to the mitotic chromosomes, ensuring distribution into both daughter nuclei. Mutations in a newly defined chromatin binding region of L2 potently blocked translocation, suggesting that translocation is dependent on chromatin binding during prometaphase. This represents the first time a virus has been shown to functionally couple the penetration of limiting membranes to cellular mitosis, explaining in part the tropism of HPV for mitotic basal keratinocytes.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Monoklonaler ANTI-FLAG® M2-Antikörper in Maus hergestellte Antikörper, clone M2, purified immunoglobulin (Purified IgG1 subclass), buffered aqueous solution (10 mM sodium phosphate, 150 mM NaCl, pH 7.4, containing 0.02% sodium azide)
Sigma-Aldrich
Actinomycin D, from Streptomyces sp., suitable for cell culture, ≥95%
Sigma-Aldrich
Hydroxyharnstoff, 98%, powder
Sigma-Aldrich
Trypsin-Inhibitor aus Glycine max (soybean), powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Proteasehemmer-Cocktail, for use in tissue culture media, DMSO solution
Sigma-Aldrich
γγ-Sekretase-Inhibitor XXI, Verbindung E, This g-secretase inhibitor, CAS 209986-17-4, is a cell-permeable, potent, selective, non-transition-state analog inhibitor of γ-secretase and Notch processing. Lowers Aβ levels in APP transgenic mice
Sigma-Aldrich
Brefeldin A aus Penicillium brefeldianum, ≥99% (HPLC and TLC), BioXtra, for molecular biology
Sigma-Aldrich
Bafilomycin A1, Streptomyces griseus, Bafilomycin A1, CAS 88899-55-2, acts as a highly potent and specific inhibitor of vacuolar-type H+-ATPase (Ki = 500 pM). Blocks the fusion of autophagosome with lysosome.
Sigma-Aldrich
Furin-Inhibitor I, Furin Inhibitor I, is a peptidyl chloromethylketone that binds to the catalytic site of furin and blocks its activity.
Sigma-Aldrich
Monastrol, ≥98% (HPLC), solid
Sigma-Aldrich
Anti-TGN46 in Kaninchen hergestellte Antikörper, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution